Anne Samuel
Stock Analyst at JP Morgan
(2.51)
# 2,408
Out of 4,996 analysts
70
Total ratings
51.16%
Success rate
1.46%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HQY HealthEquity | Maintains: Overweight | $125 → $126 | $96.53 | +30.53% | 9 | Sep 3, 2025 | |
VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $290.27 | -0.09% | 7 | Aug 28, 2025 | |
PGNY Progyny | Maintains: Neutral | $23 → $25 | $21.46 | +16.50% | 8 | Aug 26, 2025 | |
DOCS Doximity | Maintains: Neutral | $63 → $60 | $74.40 | -19.35% | 7 | May 27, 2025 | |
IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $179.56 | -1.43% | 7 | May 19, 2025 | |
OMCL Omnicell | Maintains: Neutral | $44 → $36 | $30.72 | +17.19% | 5 | Mar 20, 2025 | |
EVH Evolent Health | Maintains: Overweight | $13 → $12 | $8.95 | +34.08% | 12 | Mar 10, 2025 | |
PHR Phreesia | Maintains: Overweight | $27 → $28 | $23.62 | +18.54% | 2 | Sep 9, 2024 | |
PINC Premier | Maintains: Neutral | $21 → $19 | $27.81 | -31.68% | 4 | Sep 9, 2024 | |
CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $29.39 | -28.55% | 3 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $13 | $2.80 | +364.29% | 3 | Sep 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $37.56 | -28.12% | 2 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $3.98 | +25.63% | 1 | Jul 31, 2024 |
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $96.53
Upside: +30.53%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $290.27
Upside: -0.09%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $21.46
Upside: +16.50%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $74.40
Upside: -19.35%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $179.56
Upside: -1.43%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $30.72
Upside: +17.19%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $8.95
Upside: +34.08%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $23.62
Upside: +18.54%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $27.81
Upside: -31.68%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $29.39
Upside: -28.55%
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $2.80
Upside: +364.29%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $37.56
Upside: -28.12%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $3.98
Upside: +25.63%